Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309151723> ?p ?o ?g. }
- W4309151723 endingPage "394" @default.
- W4309151723 startingPage "386" @default.
- W4309151723 abstract "Background: Immune checkpoint inhibitors (ICIs) such as PD-1/PD-L1/CTLA-4 inhibitors have brought new opportunities for the cure of cancer patients and have been widely used and which are the most successful cancer immunotherapy drug in recent years. Gut microbiome and metabolites exert a critical regulatory function in cancer immunotherapy of ICIs, which can be affected by antibiotics intervention. However, inflammatory infections caused by impaired immune function in tumor patients often require antibiotic treatment.Objective: In this review, we briefly discussed the correlation between antibiotics and ICIs treatment to evaluate the impact of antibiotics on cancer progression.Methods: By searches of PubMed, we collected the data such as progression-free survival time (PFS) and overall survival time (OS) in patients with non-small cell lung cancer (NSCLC), kidney cancer, Melanoma, colorectal cancer, and other tumors.Results: Antibiotics have a negative effect on the prolongation of survival in cancer patients treated with ICIs. This may depend on the patient's cancer type and the type of ICIs and antibiotics they have used.Conclusions: Antibiotics may reduce the effectiveness of immunotherapy by depleting the body's microbiome. Therefore, paying attention to the changes in the level of microorganisms in cancer patients, while making more individualized and precise improvements in treatment regimens, may bring new opportunities to improve the efficacy of immunotherapy." @default.
- W4309151723 created "2022-11-24" @default.
- W4309151723 creator A5019141938 @default.
- W4309151723 creator A5052753965 @default.
- W4309151723 creator A5053620278 @default.
- W4309151723 creator A5054482344 @default.
- W4309151723 creator A5069157560 @default.
- W4309151723 creator A5082924617 @default.
- W4309151723 creator A5084592916 @default.
- W4309151723 date "2022-11-16" @default.
- W4309151723 modified "2023-09-30" @default.
- W4309151723 title "Effect of concomitant antibiotics use on patient outcomes and adverse effects in patients treated with ICIs" @default.
- W4309151723 cites W1940241680 @default.
- W4309151723 cites W2025063983 @default.
- W4309151723 cites W2066671159 @default.
- W4309151723 cites W2124632458 @default.
- W4309151723 cites W2148334703 @default.
- W4309151723 cites W2165456770 @default.
- W4309151723 cites W2182886463 @default.
- W4309151723 cites W2554479252 @default.
- W4309151723 cites W2742763599 @default.
- W4309151723 cites W2756403351 @default.
- W4309151723 cites W2765314233 @default.
- W4309151723 cites W2794616539 @default.
- W4309151723 cites W2795186863 @default.
- W4309151723 cites W2796582438 @default.
- W4309151723 cites W2809501033 @default.
- W4309151723 cites W2888394278 @default.
- W4309151723 cites W2888578355 @default.
- W4309151723 cites W2897664707 @default.
- W4309151723 cites W2913368539 @default.
- W4309151723 cites W2918152867 @default.
- W4309151723 cites W2961510294 @default.
- W4309151723 cites W2962982457 @default.
- W4309151723 cites W2972674410 @default.
- W4309151723 cites W2973481987 @default.
- W4309151723 cites W2975538531 @default.
- W4309151723 cites W2975608733 @default.
- W4309151723 cites W2978417228 @default.
- W4309151723 cites W2981030350 @default.
- W4309151723 cites W2985762613 @default.
- W4309151723 cites W2987253676 @default.
- W4309151723 cites W2990381272 @default.
- W4309151723 cites W3000170484 @default.
- W4309151723 cites W3006759251 @default.
- W4309151723 cites W3008549813 @default.
- W4309151723 cites W3009405574 @default.
- W4309151723 cites W3011314376 @default.
- W4309151723 cites W3015408469 @default.
- W4309151723 cites W3025315917 @default.
- W4309151723 cites W3041885976 @default.
- W4309151723 cites W3043217165 @default.
- W4309151723 cites W3048903784 @default.
- W4309151723 cites W3084184895 @default.
- W4309151723 cites W3089321881 @default.
- W4309151723 cites W3095710530 @default.
- W4309151723 cites W3097703961 @default.
- W4309151723 cites W3099859528 @default.
- W4309151723 cites W3105455308 @default.
- W4309151723 cites W3112000685 @default.
- W4309151723 cites W3119256894 @default.
- W4309151723 cites W3121241747 @default.
- W4309151723 cites W3124384511 @default.
- W4309151723 cites W3127098587 @default.
- W4309151723 cites W3134731856 @default.
- W4309151723 cites W3137283383 @default.
- W4309151723 cites W3138943871 @default.
- W4309151723 cites W3152298003 @default.
- W4309151723 cites W3152320455 @default.
- W4309151723 cites W3154005234 @default.
- W4309151723 cites W3168651948 @default.
- W4309151723 cites W3169907754 @default.
- W4309151723 cites W3181453493 @default.
- W4309151723 cites W3182167443 @default.
- W4309151723 cites W3186951264 @default.
- W4309151723 cites W3196999461 @default.
- W4309151723 cites W3204478304 @default.
- W4309151723 cites W4206810172 @default.
- W4309151723 cites W4285794265 @default.
- W4309151723 cites W4288445670 @default.
- W4309151723 doi "https://doi.org/10.1080/08923973.2022.2145966" @default.
- W4309151723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36382735" @default.
- W4309151723 hasPublicationYear "2022" @default.
- W4309151723 type Work @default.
- W4309151723 citedByCount "0" @default.
- W4309151723 crossrefType "journal-article" @default.
- W4309151723 hasAuthorship W4309151723A5019141938 @default.
- W4309151723 hasAuthorship W4309151723A5052753965 @default.
- W4309151723 hasAuthorship W4309151723A5053620278 @default.
- W4309151723 hasAuthorship W4309151723A5054482344 @default.
- W4309151723 hasAuthorship W4309151723A5069157560 @default.
- W4309151723 hasAuthorship W4309151723A5082924617 @default.
- W4309151723 hasAuthorship W4309151723A5084592916 @default.
- W4309151723 hasConcept C121608353 @default.
- W4309151723 hasConcept C126322002 @default.
- W4309151723 hasConcept C143121216 @default.
- W4309151723 hasConcept C143998085 @default.
- W4309151723 hasConcept C177713679 @default.